News room
Technophage among companies with higher investment in R&D
In 2019, Technophage was among the top 100 companies with the highest R&D investment in Portugal. According to the provisional results of...
TechnoPhage is certified for GMP production of biological medicines
TechnoPhage owns an innovative unit for the production of biological medicines that has now obtained authorization from INFARMED for the manufacture...
COVID-19 New Challenge: joint effort to mitigate world’s pandemic crisis
COVID-19 New Challenge: joint effort to mitigate world’s pandemic crisis (TechnoPhage S.A., Faculty of Pharmacy of University of Lisbon and Vector...
Relevance for screening antibodies in a faster and more effcient way using Technophage’s patented technologies
Since the 1st January 2020, Technophage is a resident company of Johnson & Johnson Innovation, JLABS, a premier life science incubator program....
Healthcare associated infections in COVID-19 patients
COVID-19 patients suffering from severe forms of the disease are at risk of developing bacterial healthcare-associated infections, such as...